STICTG Logo  

All STI CTG Protocols

 
invisible image
line
line
line
line
line
line
line
line
line
line
line
line
line
line
line

 

Email page link:

1 pix

STI CTG Protocols

Since its inception in 2005, the STI CTG has received a total of 89 Concepts. Each Concept was reviewed by the Executive Committee for responsiveness to the STI CTG mission. Concepts consistent with the STI CTG mission were then assessed by the Scientific Review Committee.

5 protocols are pending submission to the STI CTG

8 protocols are under development (1 protocol in collaboration)
1 study is actively enrolling participants
2 studies have reached their enrollment goals

2 studies are in data analysis
Currently, the network is facilitating 18 studies in various stages
 

Status
Title

Pending

Submission

Safety and Immunogenicity of Heplisav™ in HIV-infected Persons
   

Pending

Submission

GenProbe APTIMA Trichomonas Test - Progression to 510(k)
   

Pending

Submission

A non-inferiority trial of oral therapy (cefpodoxime 400mg & azithromycin 1gm) compared with intramuscular therapeutic injection (ceftriaxone 125mg) for treatment of pharyngeal gonorrhea
   

Pending

Submission

Phase 0 Demonstration project of an STI e-Health System for STI Diagnosis and Treatment
   
Pending Submission A RCT of Single vs. Multiple (3 Weekly) Dose Benzathine Penicillin G for Early Syphilis Therapy of Persons With and Without HIV.
   
In Development Randomized Trial of Patient Delivered Partner Therapy vs. Standard Partner Referral for Prevention of Persistent or Recurrent Chlamydial Infection and Adverse Outcomes in Pregnant Women
   

In Development

Self-Obtained Vaginal Swabs for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
   
In Development Preventing Vaginal Infections in Women at Risk for HIV-1
   
In Development Syphilis Chemoprophylaxis in Homosexual Men with HIV infection Using Doxycycline
   
In Development Randomized Clinical Trial Evaluating Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin and Combination Therapies as a Salvage Regimen for Uncomplicated Urogenital Gonorrhea
   
In Development Phase 1 Study of the Safety and Tolerability of 3% w/w SPL7013 Gel (VivaGel™) Following Rectal Administration Once Daily for Seven Days in Healthy Male and Female Volunteers
   
Enrolling Randomized Clinical Trial Evaluating Treatment Failure Following Recommended Therapy (Azithromycin versus Doxycycline) for Genital Chlamydial Infection in Females in Youth Correctional Facilities
   
Enrolling Home Screening for Bacterial Vaginosis to Prevent STDs
   
Closed to Enrollment Phase II Randomized, Placebo-Controlled Double-Blind 4-arm Trial for the Treatment of Non-Gonococcal urethritis (NGU): Doxycycline (Plus or Minus Tinidazole) Verses Azithromycin (Plus or Minus Tinidazole)
   

Closed to

Enrollment

A Phase III Equivalence Trial of Azithromycin vs. Benzathine Penicillin for the Treatment of Early Syphilis
   
Closed Assessing recruitment and enrollment strategies for STI studies
   
Closed An Expanded Phase I Randomized Placebo Controlled Trial of the Safety and Tolerability of 3% w/w SPL7013 Gel (VivaGel™) in Healthy Young Women When Administered Twice Daily for 14 Days

 


 
1 px
Partners Logo
© Copyright 2008, STI Clinical Trials Group (STICTG)
invisible